Cargando…
Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma
BACKGROUND: Pancreatic cancer is one of the principal causes of tumor-related death worldwide. CXC chemokines, a subfamily of functional chemotactic peptides, affect the initiation of tumor cells and clinical outcomes in several human malignant tumors. However, the specific biological functions and...
Autores principales: | Huang, Jiacheng, Chen, Zhitao, Ding, Chenchen, Lin, Shengzhang, Wan, Dalong, Ren, Kuiwu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8419473/ https://www.ncbi.nlm.nih.gov/pubmed/34497764 http://dx.doi.org/10.3389/fonc.2021.711402 |
Ejemplares similares
-
CXC Chemokines as Therapeutic Targets and Prognostic Biomarkers in Skin Cutaneous Melanoma Microenvironment
por: Zhou, Xuezhi, et al.
Publicado: (2021) -
Identification of Therapeutic Targets and Prognostic Biomarkers Among CXC Chemokines in the Renal Cell Carcinoma Microenvironment
por: Zeng, Qingquan, et al.
Publicado: (2020) -
Prognostic Significance and Therapeutic Target of CXC Chemokines in the Microenvironment of Lung Adenocarcinoma
por: Wang, Kun, et al.
Publicado: (2022) -
Bioinformatics, Molecular Docking and Experiments In Vitro Analyze the Prognostic Value of CXC Chemokines in Breast Cancer
por: Wang, Fei, et al.
Publicado: (2021) -
Analysis of therapeutic targets and prognostic biomarkers of CXC chemokines in cervical cancer microenvironment
por: Kong, Weina, et al.
Publicado: (2021)